Latest filing published 10 Jun 2026 for ORTHOPEDIATRICS CORP. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of David R. Bailey in Orthopediatrics Corp, where the filings describe the role as chief executive. Over a trading history stretching from 16 October 2017 to 9 June 2026, the count stands at 31 filings.
The open-market record consists of 11 sales worth €1.9M, with no purchase. The rest of the record consists of 10 share grants and 5 option exercises. 2026 to date brings no purchases and 1 sale.
On 10 June 2026 came the latest disclosure, a share grant in Orthopediatrics Corp. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations